QUINLAN AMY (Vice President of Finance) reported 1 transaction at VOR BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/8/2024ACC: 0001415889-24-026432
Officer· Vice President of Finance
Since Jun 2024
-206.00
Net shares
Net seller
$177.16
Total sold
0
Open market trades
0B · 0S
1
Total transactions
206.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−206.00
Price / share
$0.86
Trade value
$177.16
% of position
0.4%
11/6/2024
50.52K→50.31K
Total
Net shares
−206.00
Net value
-$177.16
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/6/2024 | F · Tax Withholding | −206.00 | $0.86 | $177.16 | 0.4% | 50.52K | 50.31K |
| Total | −206.00 | -$177.16 | ||||||
Derivative Transactions0
No derivative transactions reported